Learn how genetics

can affect your patients'

future family

Genetic testing before and during pregnancy

Start an order

Carrier screening

ACOG recommends that patients of reproductive age should be offered carrier screening. Carrier screening before pregnancy can provide your patients with more reproductive options, including IVF.

Learn more

Non-invasive prenatal screening (NIPS)

Assess whether a pregnancy is at increased risk for the most common chromosomal disorders.

Learn more

Miscarriage analysis

If your patient has had previous miscarriages, chromosomal microarray analysis (CMA) for pregnancy loss can provide answers for whether the loss was due to a chromosomal abnormality.

Learn more

How can your patients benefit from carrier screening?

80% of children with a genetic disorder are born to parents with no family history or symptoms of the disorder.

We believe that all women of reproductive age should be offered carrier screening and that the cost of testing should not be a barrier. Invitae provides high-quality, affordable, and actionable carrier screening for your patients.

Order carrier screening

Invitae NIPS: assess the risk of the most common chromosomal disorders

  • Our high-quality, affordable NIPS can detect fetal chromosomal abnormalities as early as 10 weeks, for all pregnant patients.

  • Invitae NIPS quickly analyzes cell-free DNA (cfDNA) to assess whether a singleton or twin pregnancy is at increased risk for the three most common chromosomal disorders on chromosomes 21, 18, and 13.

  • Add optional microdeletion and sex chromosome analysis at no additional charge, or pair with carrier screening for even more insights.

Order NIPS

Invitae Carrier Screen + Invitae NIPS 

Easily order Invitae carrier screening and NIPS testing together for the same patient 

  • Invitae offers the convenient, time-saving option to pair carrier screening and NIPS in one sample collection kit, ensuring a better, more streamlined experience for you and your patients.

Understanding miscarriage analysis

More than 50% of all early-pregnancy losses are due to a fetal chromosomal abnormality.

We believe that patients deserve answers to understand the causes of pregnancy loss and better inform the next steps on their reproductive journey.

Invitae’s chromosomal microarray analysis (CMA) technology is a critical step for helping your patients understand pregnancy loss.

Order miscarriage analysis

Taking action on patient results

All of Invitae’s women's health tests provide actionable results with access to genetic counseling resources and recommended next steps.

Carrier screening


Positive result

A positive result means that a disease-causing variant was found, and your patient is a carrier of one or more of the disorders tested. Being a carrier typically does not affect your own health; however, it does mean that there is an increased risk of having a child with that disorder.

Next steps:

  • The next step is usually to test the reproductive partner

  • Actionable, patient-friendly interactive reports are available in our patient portal to help understand results.

  • Our genetic counselors are available to speak with your patients to help them understand what their results mean for them, their children, and other family members and can also provide guidance on how and when to communicate this information to relatives.


Negative result

A negative result means that no disease-causing variants were identified for any of the disorders tested. A negative test provides reassurance to patients because the chance of having a child with any of the tested disorders is reduced. However, no test can detect all carriers, so there is still a small chance, called a residual risk, of being a carrier.

Next steps:

  • If patients have additional questions about their results, they can speak to our board-certified genetic counselors.

  • Continue on the patients' planned reproductive journey.

Miscarriage analysis



An abnormal test result means that microarray testing detected extra or missing chromosomal information, meaning that the pregnancy loss was likely due to a fetal chromosomal abnormality.

Next steps:

  • If the test result is abnormal, the report provides more specific information about the abnormality detected.

  • Your patient has access to our genetic counselors to help understand results and discuss next steps.

  • In some situations, additional studies on your patient and their reproductive partner are recommended.



A normal test result means that microarray testing did not detect any chromosomal abnormalities.

Next steps:

  • Your patient has access to our genetic counselors to discuss their results.

  • Talk to your patients about reproductive options that meet their individual needs.



A VUS result means that chromosomal microarray testing identified extra or missing genetic information but this change is not well understood or is very rare.

In this situation, it is not possible to determine with certainty whether the change of the chromosomal information was the cause of the miscarriage.

Next steps:

  • Your patient has access to our genetic counselors to help understand and interpret their results.

  • In some situations, additional studies on the patient or and their partner may be required for further clarification.

Invitae advantage

High-quality tests

Learn more

Affordable prices

Learn more

Experts on demand

Learn more

Invitae is committed to bringing high-quality genetic testing into mainstream medical practice

  • Quality testing backed by peer-reviewed studies showing 100% analytic sensitivity and specificity compared to historical hereditary cancer genetic testing laboratories.

  • Invitae performs full gene sequencing and deletion/duplication analysis on all genes unless otherwise indicated.

  • With greater detection rates than karyotyping, our chromosomal microarray analysis (CMA) for pregnancy loss can determine if a pregnancy loss or stillbirth was due to a chromosomal abnormality.

Learn more

Our pricing options make high-quality testing affordable

In order to make genetic information more accessible to all patients, Invitae is committed to providing affordable genetic testing with flexible billing options.

Learn more

Genetic counselors available on demand

We’re here to help answer you and your patients’ questions and provide support every step of the way. Invitae’s team of genetic counselors is available to:

  • Help you choose the test(s) that is most suitable for your patient

  • Aid in interpreting results

  • Provide post-test counseling for your patients at no additional charge 

Learn more

Get started

Follow these easy steps to get started with Invitae carrier screening:

1. Request free kits for collecting patient specimens

2. Order a test using Invitae’s HIPAA-compliant online portal or on paper

  • Call Clinical Consult at 800-436-3037 if you would like to review patient cases or differentiate between testing options.

  • Patients can also contact Client Services for billing and insurance-related questions.

3. Receive an email when your results are ready (10-21 calendar days, on average)

  • If you have any questions about the results or their clinical implications, our genetic counselors are available to discuss.

Click here to get started with ordering miscarriage analysis for your patients.

Go back to women's health page

Women's health